EUVIMEDEUVIMED entdecken
Validierungsstudie

Validation of the PEN‐FAST Penicillin Allergy Clinical Decision Rule in an Asian Cohort

Xin Rong Lim iD, Ryan Xuan Wei Teo, Justina Wei-Lyn Tan, Sze-Chin Tan, Khai-Pang Leong iD, Faith Li-Ann Chia, Samuel Shang-Ming Lee, Claire Min-Li Teo iD, Grace Yin-Lai Chan, Bernard Yu-Hor Thong iD

Clinical & Experimental Allergy · 2026-04 · 56 (4) · 402-410

DOI: 10.1111/cea.70164 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Clinical & Experimental Allergy, online erschienen am 25.10.2025. Verfasst von Xin Rong Lim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Penicillins, Clinical Decision Rules, Anti-Bacterial Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

A false penicillin allergy label often leads to the unnecessary avoidance of beta‐lactam antibiotics, contributing to antimicrobial resistance and suboptimal clinical outcomes. The PEN‐FAST clinical decision rule is a simple, point‐of‐care tool with a high negative predictive value (NPV) designed to identify low‐risk patients who may not require extensive allergy testing. This study aims to validate the performance of the PEN‐FAST clinical decision rule in an Asian population.

Methods

A retrospective review of medical records from January 2006 to February 2023 was conducted at our institution's outpatient allergy clinic. Patients underwent skin prick and intradermal testing, followed by oral drug provocation testing (DPT) or direct oral DPT without prior skin testing (ST). Positive results were defined as positive skin test outcomes or immediate/delayed reactions following drug challenge. PEN‐FAST scores were compared to allergy testing results.

Results

A total of 357 patients were included, with 85 (23.8%) undergoing direct DPT without prior ST. None had a history of severe cutaneous allergic reaction as their index reaction. The median age was 49 years (interquartile range [IQR]: 34–63), and 61.9% were female. Forty‐seven patients (13.2%) had positive test results, including 26 positive reactions following DPT. PEN‐FAST scores of 0–5 were distributed as follows: 25 (7.0%), 159 (44.5%), 31 (8.7%), 96 (26.9%), 4 (1.1%) and 42 (11.8%). Among those with PEN‐FAST scores ≤ 2 ( n = 215), 16 (7.4%) had a positive test. Of these, 7 developed urticaria, 8 developed mild delayed maculopapular exanthem and 1 had a positive skin test. A PEN‐FAST score cutoff of ≤ 2 yielded sensitivity of 66.0% (95% CI: 50.7%–79.1%), specificity of 64.2% (95% CI: 58.6%–69.5%), a positive predictive value (PPV) of 21.8% (95% CI: 17.8%–26.5%) and a NPV of 92.6% (95% CI: 89.2%–94.9%). The area under the receiver operating characteristic curve was 0.66 (95% CI: 0.58–0.75).

Conclusion

The PEN‐FAST clinical decision rule demonstrates a high NPV in an Asian population, supporting its potential utility in identifying individuals unlikely to have true penicillin allergy and enabling direct DPT in low‐risk patients without prior ST. However, the modest area under the curve (AUC) of 0.66 reflects limited overall discriminatory ability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug HypersensitivityPenicillinsClinical Decision RulesAnti-Bacterial AgentsHumansFemaleMiddle AgedMaleAdultRetrospective StudiesSkin TestsAsian PeoplePredictive Value of Tests

Stichwörter der Autor:innen

PEN‐FASTallergyde‐labellingdrug provocation testingpenicillin

Substanzen

PenicillinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore.

ORCID-Profile: Xin Rong Lim, Khai-Pang Leong, Claire Min-Li Teo, Bernard Yu-Hor Thong

Zitieren

APA

Lim, X. R., Teo, R. X. W., Tan, J. W., Tan, S. C., Leong, K. P., Chia, F. L., Lee, S. S., Teo, C. M., Chan, G. Y., & Thong, B. Y. (2026). Validation of the PEN‐FAST Penicillin Allergy Clinical Decision Rule in an Asian Cohort. Clinical & Experimental Allergy, 56(4), 402-410. https://doi.org/10.1111/cea.70164

Vancouver

Lim XR, Teo RXW, Tan JW, Tan SC, Leong KP, Chia FL, et al. Validation of the PEN‐FAST Penicillin Allergy Clinical Decision Rule in an Asian Cohort. Clinical & Experimental Allergy. 2026;56(4):402-410. doi:10.1111/cea.70164

BibTeX
@article{Lim2026,
  author = {Lim, Xin Rong and Teo, Ryan Xuan Wei and Tan, Justina Wei-Lyn and Tan, Sze-Chin and Leong, Khai-Pang and Chia, Faith Li-Ann and Lee, Samuel Shang-Ming and Teo, Claire Min-Li and Chan, Grace Yin-Lai and Thong, Bernard Yu-Hor},
  title = {Validation of the PEN‐FAST Penicillin Allergy Clinical Decision Rule in an Asian Cohort},
  journal = {Clinical & Experimental Allergy},
  year = {2026},
  volume = {56},
  number = {4},
  pages = {402--410},
  doi = {10.1111/cea.70164}
}
Kostenlos starten →